
VIGL Valuation
Vigil Neuroscience Inc
- Overview
- Forecast
- Valuation
- Earnings
VIGL Relative Valuation
VIGL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VIGL is overvalued; if below, it's undervalued.
Historical Valuation
Vigil Neuroscience Inc (VIGL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.92. The fair price of Vigil Neuroscience Inc (VIGL) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:8.06
Fair
-4.64
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Vigil Neuroscience Inc. (VIGL) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -1.17. The thresholds are as follows: Strongly Undervalued below -4.51, Undervalued between -4.51 and -2.84, Fairly Valued between 0.50 and -2.84, Overvalued between 0.50 and 2.17, and Strongly Overvalued above 2.17. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-3.01
EV/EBIT
Vigil Neuroscience Inc. (VIGL) has a current EV/EBIT of -3.01. The 5-year average EV/EBIT is -1.38. The thresholds are as follows: Strongly Undervalued below -4.86, Undervalued between -4.86 and -3.12, Fairly Valued between 0.36 and -3.12, Overvalued between 0.36 and 2.09, and Strongly Overvalued above 2.09. The current Forward EV/EBIT of -3.01 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
Vigil Neuroscience Inc. (VIGL) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
-3.81
P/OCF
Vigil Neuroscience Inc. (VIGL) has a current P/OCF of -3.81. The 5-year average P/OCF is -2.56. The thresholds are as follows: Strongly Undervalued below -5.73, Undervalued between -5.73 and -4.14, Fairly Valued between -0.97 and -4.14, Overvalued between -0.97 and 0.61, and Strongly Overvalued above 0.61. The current Forward P/OCF of -3.81 falls within the Historic Trend Line -Fairly Valued range.
-4.40
P/FCF
Vigil Neuroscience Inc. (VIGL) has a current P/FCF of -4.40. The 5-year average P/FCF is -2.64. The thresholds are as follows: Strongly Undervalued below -5.93, Undervalued between -5.93 and -4.29, Fairly Valued between -0.99 and -4.29, Overvalued between -0.99 and 0.65, and Strongly Overvalued above 0.65. The current Forward P/FCF of -4.40 falls within the Undervalued range.
Vigil Neuroscience Inc (VIGL) has a current Price-to-Book (P/B) ratio of 5.77. Compared to its 3-year average P/B ratio of 1.77 , the current P/B ratio is approximately 225.90% higher. Relative to its 5-year average P/B ratio of 1.53, the current P/B ratio is about 276.76% higher. Vigil Neuroscience Inc (VIGL) has a Forward Free Cash Flow (FCF) yield of approximately -13.95%. Compared to its 3-year average FCF yield of -38.61%, the current FCF yield is approximately -63.88% lower. Relative to its 5-year average FCF yield of -37.84% , the current FCF yield is about -63.14% lower.
5.77
P/B
Median3y
1.77
Median5y
1.53
-13.95
FCF Yield
Median3y
-38.61
Median5y
-37.84
Competitors Valuation Multiple
The average P/S ratio for VIGL's competitors is 27.82, providing a benchmark for relative valuation. Vigil Neuroscience Inc Corp (VIGL) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of VIGL increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of VIGL in the past 1 year is driven by Unknown.
People Also Watch

CTM
Castellum Inc
1.000
USD
-2.91%

WLGS
WANG & LEE GROUP Inc
0
USD
-6.82%

AUBN
Auburn National Bancorporation Inc
25.808
USD
+6.16%

ATMC
Alphatime Acquisition Corp
11.870
USD
-2.63%

ANIX
Anixa Biosciences Inc
2.990
USD
-0.66%

INCR
InterCure Ltd
1.580
USD
-2.35%

CATO
Cato Corp
4.110
USD
+4.58%

CAPN
Cayson Acquisition Corp
10.370
USD
-0.10%

EPIX
ESSA Pharma Inc
0.240
USD
+2.13%

PBHC
Pathfinder Bancorp Inc (MARYLAND)
14.920
USD
0.00%
FAQ

Is Vigil Neuroscience Inc (VIGL) currently overvalued or undervalued?
Vigil Neuroscience Inc (VIGL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.92. The fair price of Vigil Neuroscience Inc (VIGL) is between to according to relative valuation methord.

What is Vigil Neuroscience Inc (VIGL) fair value?

How does VIGL's valuation metrics compare to the industry average?

What is the current P/B ratio for Vigil Neuroscience Inc (VIGL) as of Aug 30 2025?

What is the current FCF Yield for Vigil Neuroscience Inc (VIGL) as of Aug 30 2025?

What is the current Forward P/E ratio for Vigil Neuroscience Inc (VIGL) as of Aug 30 2025?
